Pub Date : 2025-05-01Epub Date: 2025-07-27DOI: 10.1080/13546805.2025.2529791
Charley Hillier, Nathan Weber, Ryan P Balzan
Introduction: People with psychosis place greater confidence in errors and less confidence in accurate judgements relative to controls. This overconfidence in errors bias is theorised to contribute to the formation and maintenance of delusions. However, no research has examined whether people with psychosis have an impaired ability to judge whether they are confident or not, known as resolution. This study aimed to establish whether psychosis populations show a resolution deficit.
Method: We used hierarchical Bayesian modelling and Type 2 Signal Detection Theory to explore whether participants with schizophrenia (n = 25) had poorer resolution and higher overconfidence than high delusion-prone (n = 25) and low delusion-prone participants (n = 25) when making confidence judgements. A discrimination index and over/underconfidence statistic examined resolution and overconfidence, respectively.
Results: While all participants showed a low discrimination index, schizophrenia participants had a meaningfully lower discrimination index than low delusion-prone participants, indicating poorer resolution. All groups were overconfident, with schizophrenia participants showing the greatest level of overconfidence.
Conclusions: Results suggest schizophrenia patients show impairments in using confidence judgements to discriminate between correct and incorrect judgements. Resolution deficits in psychosis could have theoretical and clinical implications for our approach towards delusions.
{"title":"Overconfidence or resolution in psychosis: a Bayesian reanalysis.","authors":"Charley Hillier, Nathan Weber, Ryan P Balzan","doi":"10.1080/13546805.2025.2529791","DOIUrl":"10.1080/13546805.2025.2529791","url":null,"abstract":"<p><strong>Introduction: </strong>People with psychosis place greater confidence in errors and less confidence in accurate judgements relative to controls. This overconfidence in errors bias is theorised to contribute to the formation and maintenance of delusions. However, no research has examined whether people with psychosis have an impaired ability to judge whether they are confident or not, known as resolution. This study aimed to establish whether psychosis populations show a resolution deficit.</p><p><strong>Method: </strong>We used hierarchical Bayesian modelling and Type 2 Signal Detection Theory to explore whether participants with schizophrenia (<i>n</i> = 25) had poorer resolution and higher overconfidence than high delusion-prone (<i>n</i> = 25) and low delusion-prone participants (<i>n</i> = 25) when making confidence judgements. A discrimination index and over/underconfidence statistic examined resolution and overconfidence, respectively.</p><p><strong>Results: </strong>While all participants showed a low discrimination index, schizophrenia participants had a meaningfully lower discrimination index than low delusion-prone participants, indicating poorer resolution. All groups were overconfident, with schizophrenia participants showing the greatest level of overconfidence.</p><p><strong>Conclusions: </strong>Results suggest schizophrenia patients show impairments in using confidence judgements to discriminate between correct and incorrect judgements. Resolution deficits in psychosis could have theoretical and clinical implications for our approach towards delusions.</p>","PeriodicalId":51277,"journal":{"name":"Cognitive Neuropsychiatry","volume":" ","pages":"186-198"},"PeriodicalIF":0.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144735180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-01Epub Date: 2025-08-04DOI: 10.1080/13546805.2025.2539159
Aarush Mehta, Amir H Nikzad, Yan Cong, Sunghye Cho, Sameer Pradhan, Sunny X Tang
Background: Sentiment in the speech of people with schizophrenia spectrum disorder (SSD) may reflect psychosis severity. Previous research examines speech from semi-structured interviews or self-narrative prompts, where differences in measured sentiment may be driven by differences in life experiences. We measured sentiment in speech evoked from standardised stimuli among participants with a psychotic disorder.
Methods: Two cohorts (N = 97) participated in this study. Symptom domains were assessed using the Brief Psychiatric Rating Scale and were represented as Anxious Depression, Hostile Suspiciousness, Thought Disturbance, and Withdrawal Retardation. Participant speech during picture description tasks was quantified for sentiments: Valence, Arousal, Dominance, Happiness, Sadness, Anger, Fear, Disgust, and Surprise. Correlations between clinical and sentiment measures were conducted separately for the two cohorts and two timepoints in Cohort 1. Within-participant longitudinal relationships were examined with linear mixed models.
Results: Several replicable relationships between sentiment and symptom severity were found: two replicable findings among Cohorts 1 and 2 and three replicable findings across Cohort 1 timepoints. Five findings were also generalised to within-participant longitudinal relationships.
Conclusions: Sentiment measures were related to the four symptom domains in the context of standardised stimuli, suggesting a disruption in emotion processing among people with a psychotic disorder.
{"title":"Sentiment in speech is associated with symptom severity in psychosis.","authors":"Aarush Mehta, Amir H Nikzad, Yan Cong, Sunghye Cho, Sameer Pradhan, Sunny X Tang","doi":"10.1080/13546805.2025.2539159","DOIUrl":"10.1080/13546805.2025.2539159","url":null,"abstract":"<p><strong>Background: </strong>Sentiment in the speech of people with schizophrenia spectrum disorder (SSD) may reflect psychosis severity. Previous research examines speech from semi-structured interviews or self-narrative prompts, where differences in measured sentiment may be driven by differences in life experiences. We measured sentiment in speech evoked from standardised stimuli among participants with a psychotic disorder.</p><p><strong>Methods: </strong>Two cohorts (<i>N</i> = 97) participated in this study. Symptom domains were assessed using the Brief Psychiatric Rating Scale and were represented as <i>Anxious Depression</i>, <i>Hostile Suspiciousness</i>, <i>Thought Disturbance</i>, and <i>Withdrawal Retardation</i>. Participant speech during picture description tasks was quantified for sentiments: <i>Valence</i>, <i>Arousal</i>, <i>Dominance</i>, <i>Happiness</i>, <i>Sadness</i>, <i>Anger</i>, <i>Fear</i>, <i>Disgust</i>, and <i>Surprise</i>. Correlations between clinical and sentiment measures were conducted separately for the two cohorts and two timepoints in Cohort 1. Within-participant longitudinal relationships were examined with linear mixed models.</p><p><strong>Results: </strong>Several replicable relationships between sentiment and symptom severity were found: two replicable findings among Cohorts 1 and 2 and three replicable findings across Cohort 1 timepoints. Five findings were also generalised to within-participant longitudinal relationships.</p><p><strong>Conclusions: </strong>Sentiment measures were related to the four symptom domains in the context of standardised stimuli, suggesting a disruption in emotion processing among people with a psychotic disorder.</p>","PeriodicalId":51277,"journal":{"name":"Cognitive Neuropsychiatry","volume":" ","pages":"199-210"},"PeriodicalIF":0.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12822357/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144776848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-01Epub Date: 2025-02-19DOI: 10.1080/13546805.2025.2464728
Jenna N Pablo, Jorja Shires, Wendy A Torrens, Lena L Kemmelmeier, Sarah M Haigh, Marian E Berryhill
Introduction: Autism spectrum disorder (ASD) and schizophrenia spectrum disorder (SSD) share some symptoms. We conducted machine learning classification to determine if common screeners used for research in non-clinical and subclinical populations, the Autism-Spectrum Quotient (AQ) and Schizotypal Personality Questionnaire - Brief Revised (SPQ-BR), could identify non-overlapping symptoms.
Methods: 1,397 undergraduates completed the SPQ-BR and AQ. Random forest classification modelled whether SPQ-BR item scores predicted AQ scores and factors, and vice versa. The models first used all item scores and then the least/most important features.
Results: Robust trait overlap allows for the prediction of AQ from SPQ-BR and vice versa. Results showed that AQ item scores predicted 2 of 3 SPQ-BR factors (disorganised, interpersonal), and SPQ-BR item scores successfully predicted 2 of 5 AQ factors (communication, social skills). Importantly, classification model failures showed that AQ item scores could not predict the SPQ-BR cognitive-perceptual factor, and the SPQ-BR item scores could not predict 3 AQ factors (imagination, attention to detail, attention switching).
Conclusions: Overall, the SPQ-BR and AQ measure overlapping symptoms that can be isolated to some factors. Importantly, where we observe model failures, we capture distinctive factors. We provide guidance for leveraging existing screeners to avert misdiagnosis and advancing specific/selective biomarker identification.
{"title":"Identifying overlapping and distinctive traits of autism and schizophrenia using machine learning classification.","authors":"Jenna N Pablo, Jorja Shires, Wendy A Torrens, Lena L Kemmelmeier, Sarah M Haigh, Marian E Berryhill","doi":"10.1080/13546805.2025.2464728","DOIUrl":"10.1080/13546805.2025.2464728","url":null,"abstract":"<p><strong>Introduction: </strong>Autism spectrum disorder (ASD) and schizophrenia spectrum disorder (SSD) share some symptoms. We conducted machine learning classification to determine if common screeners used for research in non-clinical and subclinical populations, the Autism-Spectrum Quotient (AQ) and Schizotypal Personality Questionnaire - Brief Revised (SPQ-BR), could identify <i>non-overlapping</i> symptoms.</p><p><strong>Methods: </strong>1,397 undergraduates completed the SPQ-BR and AQ. Random forest classification modelled whether SPQ-BR item scores predicted AQ scores and factors, and vice versa. The models first used all item scores and then the least/most important features.</p><p><strong>Results: </strong>Robust trait overlap allows for the prediction of AQ from SPQ-BR and vice versa. Results showed that AQ <i>item scores</i> predicted 2 of 3 SPQ-BR factors (disorganised, interpersonal), and SPQ-BR <i>item scores</i> successfully predicted 2 of 5 AQ factors (communication, social skills). Importantly, classification model <u>failures</u> showed that AQ <i>item scores</i> could not predict the SPQ-BR <i>cognitive-perceptual</i> factor, and the SPQ-BR <i>item scores</i> could not predict 3 AQ factors (imagination, attention to detail, attention switching).</p><p><strong>Conclusions: </strong>Overall, the SPQ-BR and AQ measure overlapping symptoms that can be isolated to some factors. Importantly, where we observe model failures, we capture distinctive factors. We provide guidance for leveraging existing screeners to avert misdiagnosis and advancing specific/selective biomarker identification.</p>","PeriodicalId":51277,"journal":{"name":"Cognitive Neuropsychiatry","volume":" ","pages":"69-91"},"PeriodicalIF":1.5,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12181056/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-01Epub Date: 2025-05-04DOI: 10.1080/13546805.2025.2490793
Gertrude Okello, Norman Poole, Daniel Chung
Introduction: Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a hereditary condition primarily caused by mutations on the NOTCH3 gene, leading to hypoperfusion and ischaemic events, with two-thirds of cases having lacunar infarcts mostly within the basal ganglia, thalamus, and brainstem. Here, we focus on an individual with CADASIL who had a thalamic stroke, which preceded symptoms of visual and somatic disturbances.
Methods: A single-case report is used to describe the visual and somatic disturbances experienced by a 52-year-old gentleman following a left-sided thalamic stroke, who is genetically heterozygous for c449A > G p.(Tyr150Cys) mutation in the NOTCH3 gene consistent with CADASIL, as well as their response to various psychotropic medications, through information gathered from the patient's clinical records.
Results: After trialling several antidepressants, and a trial of a cholinesterase inhibitor, there was no perceived benefit reported; with only lamotrigine, previously prescribed for thalamic pain, and olanzapine, providing the least amount of distress associated with their symptoms.
Conclusions: As the management of CADASIL appears to focus on symptom control, this case highlights the need for further research to elucidate the mechanisms driving such unusual perceptual disturbances to inform potential future treatments.
脑常染色体显性动脉病变伴皮层下梗死和脑白质病(CADASIL)是一种主要由NOTCH3基因突变引起的遗传性疾病,导致灌注不足和缺血事件,三分之二的病例发生腔隙性梗死,主要发生在基底节区、丘脑和脑干。在这里,我们关注的是一个患有CADASIL的个体,他有丘脑中风,在视觉和躯体障碍症状之前。方法:通过收集患者临床记录的信息,对一名52岁的左侧丘脑卒中患者(NOTCH3基因c449A b> G .(Tyr150Cys)突变与CADASIL一致)发生后的视觉和躯体障碍以及对各种精神药物的反应进行单例报告。结果:在试验了几种抗抑郁药和一种胆碱酯酶抑制剂后,没有发现明显的益处;仅使用拉莫三嗪(以前用于治疗丘脑疼痛)和奥氮平(与症状相关的痛苦最少)。结论:由于CADASIL的治疗似乎侧重于症状控制,本病例强调需要进一步研究阐明驱动这种不寻常的感知障碍的机制,以便为潜在的未来治疗提供信息。
{"title":"\"String hallucinations\": a case of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) with multimodal visual and somatic disturbances.","authors":"Gertrude Okello, Norman Poole, Daniel Chung","doi":"10.1080/13546805.2025.2490793","DOIUrl":"10.1080/13546805.2025.2490793","url":null,"abstract":"<p><strong>Introduction: </strong>Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a hereditary condition primarily caused by mutations on the NOTCH3 gene, leading to hypoperfusion and ischaemic events, with two-thirds of cases having lacunar infarcts mostly within the basal ganglia, thalamus, and brainstem. Here, we focus on an individual with CADASIL who had a thalamic stroke, which preceded symptoms of visual and somatic disturbances.</p><p><strong>Methods: </strong>A single-case report is used to describe the visual and somatic disturbances experienced by a 52-year-old gentleman following a left-sided thalamic stroke, who is genetically heterozygous for c449A > G p.(Tyr150Cys) mutation in the NOTCH3 gene consistent with CADASIL, as well as their response to various psychotropic medications, through information gathered from the patient's clinical records.</p><p><strong>Results: </strong>After trialling several antidepressants, and a trial of a cholinesterase inhibitor, there was no perceived benefit reported; with only lamotrigine, previously prescribed for thalamic pain, and olanzapine, providing the least amount of distress associated with their symptoms.</p><p><strong>Conclusions: </strong>As the management of CADASIL appears to focus on symptom control, this case highlights the need for further research to elucidate the mechanisms driving such unusual perceptual disturbances to inform potential future treatments.</p>","PeriodicalId":51277,"journal":{"name":"Cognitive Neuropsychiatry","volume":" ","pages":"92-103"},"PeriodicalIF":1.5,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143994068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-01Epub Date: 2025-05-23DOI: 10.1080/13546805.2025.2502618
Hanna McCabe-Bennett, Kesaan Kandasamy, Alison E Carney, Richard Lachman, Todd A Girard, Martin M Antony
Introduction: Hoarding disorder represents a considerable health concern that warrants further investigation of its associated neuropsychological components. The present study examined a key aspect of the cognitive-behavioural model of hoarding, information processing (memory, attention, decision making, categorisation). Mixed findings in the literature on the presence of cognitive deficits may be attributable to the use of assessment tools with low ecological validity. Thus, novel virtual reality (VR) environments were developed to examine the information-processing components with improved ecological validity.
Methods: Two groups (i.e., with hoarding disorder, n = 36; without hoarding disorder, n = 40) similar in age and gender were recruited from the community to complete a series of standardised and novel VR memory and decision-making tasks, and to complete a categorisation task for objects in a messy VR home office.
Results: Higher attentional difficulties related to ADHD symptoms, poorer category efficiency, and poorer trait, but not state, memory confidence, were reported in the hoarding group. There was no evidence of memory and decision-making impairments specific to the hoarding group.
Conclusions: Results from this research advance our understanding of the cognitive-behavioural components of hoarding and offer implications for future treatment and VR research initiatives.
{"title":"Investigating the neuropsychological features of hoarding disorder using a novel virtual reality paradigm.","authors":"Hanna McCabe-Bennett, Kesaan Kandasamy, Alison E Carney, Richard Lachman, Todd A Girard, Martin M Antony","doi":"10.1080/13546805.2025.2502618","DOIUrl":"10.1080/13546805.2025.2502618","url":null,"abstract":"<p><strong>Introduction: </strong>Hoarding disorder represents a considerable health concern that warrants further investigation of its associated neuropsychological components. The present study examined a key aspect of the cognitive-behavioural model of hoarding, <i>information processing</i> (memory, attention, decision making, categorisation). Mixed findings in the literature on the presence of cognitive deficits may be attributable to the use of assessment tools with low ecological validity. Thus, novel virtual reality (VR) environments were developed to examine the information-processing components with improved ecological validity.</p><p><strong>Methods: </strong>Two groups (i.e., with hoarding disorder, <i>n</i> = 36; without hoarding disorder, <i>n</i> = 40) similar in age and gender were recruited from the community to complete a series of standardised and novel VR memory and decision-making tasks, and to complete a categorisation task for objects in a messy VR home office.</p><p><strong>Results: </strong>Higher attentional difficulties related to ADHD symptoms, poorer category efficiency, and poorer trait, but not state, memory confidence, were reported in the hoarding group. There was no evidence of memory and decision-making impairments specific to the hoarding group.</p><p><strong>Conclusions: </strong>Results from this research advance our understanding of the cognitive-behavioural components of hoarding and offer implications for future treatment and VR research initiatives.</p>","PeriodicalId":51277,"journal":{"name":"Cognitive Neuropsychiatry","volume":" ","pages":"104-126"},"PeriodicalIF":1.5,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144129543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: The potential link between metabolic syndrome (MetS) and the risk of dementia or cognitive impairment remains uncertain. This study aimed to assess the association between MetS and cognitive decline through a comprehensive review and meta-analysis of the existing literature.
Methods: A systematic search was conducted in Medline (PubMed), Web of Science, Scopus and Embase up to January 2023. Eligible studies included cohort and case-control designs. Statistical analyses were performed using STATA version 17.
Results: A total of 20 studies comprising 5,727,594 participants were included. The pooled relative risk (RR) of cognitive impairment among individuals with MetS was 1.34 (95% CI: 1.25-1.43), indicating a significant association. Subgroup analyses revealed that the NCEP-ATP III criteria more effectively identified this relationship compared to other diagnostic methods. The association appeared strongest in Asian populations, followed by European and American groups.
Conclusion: This meta-analysis supports a significant association between MetS and cognitive impairment. Geographic variation in the strength of this relationship may be influenced by differences in diagnostic criteria and lifestyle factors. The findings underscore the importance of early screening and the development of region-specific public health interventions to mitigate cognitive decline in individuals with MetS.
背景:代谢综合征(MetS)与痴呆或认知障碍风险之间的潜在联系仍不确定。本研究旨在通过对现有文献的综合回顾和荟萃分析来评估MetS与认知能力下降之间的关系。方法:系统检索截至2023年1月的Medline (PubMed)、Web of Science、Scopus和Embase数据库。符合条件的研究包括队列和病例对照设计。使用STATA version 17进行统计分析。结果:共纳入20项研究,包括5,727,594名参与者。met患者认知障碍的合并相对危险度(RR)为1.34 (95% CI: 1.25-1.43),表明两者存在显著关联。亚组分析显示,与其他诊断方法相比,NCEP-ATP III标准更有效地确定了这种关系。这种关联在亚洲人群中表现得最为明显,其次是欧洲和美国人群。结论:该荟萃分析支持MetS与认知障碍之间的显著关联。这种关系强度的地理差异可能受到诊断标准和生活方式因素差异的影响。研究结果强调了早期筛查和发展特定区域的公共卫生干预措施的重要性,以减轻met患者的认知能力下降。
{"title":"Association between metabolic syndrome and cognitive impairment: a meta-analysis of analytical observational studies.","authors":"Mobin Azami, Maryam Afraie, Pardis Mohammadzadeh, Asra Moradkhani, Matin Shanazari, Danial Soltanian, Yousef Moradi","doi":"10.1080/13546805.2025.2503445","DOIUrl":"10.1080/13546805.2025.2503445","url":null,"abstract":"<p><strong>Background: </strong>The potential link between metabolic syndrome (MetS) and the risk of dementia or cognitive impairment remains uncertain. This study aimed to assess the association between MetS and cognitive decline through a comprehensive review and meta-analysis of the existing literature.</p><p><strong>Methods: </strong>A systematic search was conducted in Medline (PubMed), Web of Science, Scopus and Embase up to January 2023. Eligible studies included cohort and case-control designs. Statistical analyses were performed using STATA version 17.</p><p><strong>Results: </strong>A total of 20 studies comprising 5,727,594 participants were included. The pooled relative risk (RR) of cognitive impairment among individuals with MetS was 1.34 (95% CI: 1.25-1.43), indicating a significant association. Subgroup analyses revealed that the NCEP-ATP III criteria more effectively identified this relationship compared to other diagnostic methods. The association appeared strongest in Asian populations, followed by European and American groups.</p><p><strong>Conclusion: </strong>This meta-analysis supports a significant association between MetS and cognitive impairment. Geographic variation in the strength of this relationship may be influenced by differences in diagnostic criteria and lifestyle factors. The findings underscore the importance of early screening and the development of region-specific public health interventions to mitigate cognitive decline in individuals with MetS.</p>","PeriodicalId":51277,"journal":{"name":"Cognitive Neuropsychiatry","volume":" ","pages":"127-147"},"PeriodicalIF":1.5,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144112651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-02-21DOI: 10.1080/13546805.2025.2464726
Rachida Belaich
Background: Research into brain mechanisms and their impact on quality of life has gained significant traction, emphasising stress management, cognitive enhancement, and emotional well-being as essential components.
Objective: This study explores the relationship between brain health and overall wellness, focusing on neurobiological mechanisms and evidence-based interventions that enhance stress resilience in neurodivergent populations.
Methods: A comprehensive review of neuroscience and psychological literature was conducted, including neuroimaging and behavioural studies to assess the effectiveness of various interventions.
Results: Findings indicate that targeted strategies - such as Acceptance and Commitment Therapy (ACT), cognitive training, and lifestyle modifications - significantly improve stress resilience, cognitive abilities, and emotional regulation. Key brain regions involved include the amygdala, prefrontal cortex, and hippocampus.
Conclusions: Implementing evidence-based interventions fosters improved quality of life through enhanced brain wellness. Future research should focus on scalable approaches that are inclusive of diverse populations.
{"title":"The Brain-Wellness Nexus: exploring neurobiological mechanisms and evidence-based interventions for stress resilience in neurodivergent populations.","authors":"Rachida Belaich","doi":"10.1080/13546805.2025.2464726","DOIUrl":"10.1080/13546805.2025.2464726","url":null,"abstract":"<p><strong>Background: </strong>Research into brain mechanisms and their impact on quality of life has gained significant traction, emphasising stress management, cognitive enhancement, and emotional well-being as essential components.</p><p><strong>Objective: </strong>This study explores the relationship between brain health and overall wellness, focusing on neurobiological mechanisms and evidence-based interventions that enhance stress resilience in neurodivergent populations.</p><p><strong>Methods: </strong>A comprehensive review of neuroscience and psychological literature was conducted, including neuroimaging and behavioural studies to assess the effectiveness of various interventions.</p><p><strong>Results: </strong>Findings indicate that targeted strategies - such as Acceptance and Commitment Therapy (ACT), cognitive training, and lifestyle modifications - significantly improve stress resilience, cognitive abilities, and emotional regulation. Key brain regions involved include the amygdala, prefrontal cortex, and hippocampus.</p><p><strong>Conclusions: </strong>Implementing evidence-based interventions fosters improved quality of life through enhanced brain wellness. Future research should focus on scalable approaches that are inclusive of diverse populations.</p>","PeriodicalId":51277,"journal":{"name":"Cognitive Neuropsychiatry","volume":" ","pages":"15-30"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143469248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-04-11DOI: 10.1080/13546805.2025.2490054
Clare M Eddy
Introduction and method: Over the last few decades many studies have demonstrated that various populations with movement disorder exhibit a variety of difficulties with social cognition. This brief review paper summarises the major findings of social cognitive research conducted in various hypo- and hyper-kinetic movement disorders (Parkinson's disease, Huntington's disease and Tourette syndrome), with a focus on findings that may shed new light on the functions of the basal ganglia.Results: Task impairments include more predictable difficulties with embodied processes involving the motor system, such as problems with facial expressions and other non-verbal gestures. The cognitive and emotional changes associated with broader frontostriatal dysfunction may also explain some deficits, particularly difficulties with verbal tasks or perspective taking, with impacts varying according to the type of disorder and disease stage. Most intriguingly, transdiagnostic comparisons reveal patterns implying that the role of the basal ganglia in social cognition may be more important than previously recognised.Conclusions: Movement disorders show remarkable overlap in terms of atypical intention attribution across various tasks, as well as relationships between social cognition and behavioural or motivational symptoms (e.g., apathy; anhedonia; impulsivity). The possible mechanisms underlying these similarities are explored with a view to guiding future research.
{"title":"Basal ganglia contributions to social cognition: evidence from movement disorders.","authors":"Clare M Eddy","doi":"10.1080/13546805.2025.2490054","DOIUrl":"https://doi.org/10.1080/13546805.2025.2490054","url":null,"abstract":"<p><p><i>Introduction and method:</i> Over the last few decades many studies have demonstrated that various populations with movement disorder exhibit a variety of difficulties with social cognition. This brief review paper summarises the major findings of social cognitive research conducted in various hypo- and hyper-kinetic movement disorders (Parkinson's disease, Huntington's disease and Tourette syndrome), with a focus on findings that may shed new light on the functions of the basal ganglia.<i>Results:</i> Task impairments include more predictable difficulties with embodied processes involving the motor system, such as problems with facial expressions and other non-verbal gestures. The cognitive and emotional changes associated with broader frontostriatal dysfunction may also explain some deficits, particularly difficulties with verbal tasks or perspective taking, with impacts varying according to the type of disorder and disease stage. Most intriguingly, transdiagnostic comparisons reveal patterns implying that the role of the basal ganglia in social cognition may be more important than previously recognised.<i>Conclusions:</i> Movement disorders show remarkable overlap in terms of atypical intention attribution across various tasks, as well as relationships between social cognition and behavioural or motivational symptoms (e.g., apathy; anhedonia; impulsivity). The possible mechanisms underlying these similarities are explored with a view to guiding future research.</p>","PeriodicalId":51277,"journal":{"name":"Cognitive Neuropsychiatry","volume":"30 1","pages":"1-14"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144042780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-04-02DOI: 10.1080/13546805.2025.2482539
Elisa Caselani, Alessandra Martinelli, Chiara Grigis, Manuel Zamparini, Elena Toffol, Philip D Harvey, Matteo C Malvezzi, Giovanni de Girolamo
Aim: Schizophrenia spectrum disorders (SSD) are associated with disturbances in emotional experience, but sex differences and comparisons to healthy controls (HC) remain poorly explored. This exploratory study used Experience Sampling Method (ESM) to examine emotional variability, instability and daily/hourly patterns of positive and negative emotions across sexes in SSD and HC.
Methods: A total of 103 SSD participants (47.9%) were compared to 112 HC (52.1%), matched for sex and age. Data on sociodemographics, clinical status, functioning and quality of life were collected. ESM assessed emotional experiences over one week.
Results: For positive emotions, HC males reported higher levels on weekdays and morning-to-midday hours, whereas no sex differences emerged in SSD. Males with SSD showed greater weekly variability in positive emotions than HC males, while no significant differences were found among females. For negative emotions, females with SSD exhibited greater daily variability than female HC, with no significant sex differences within HC or SSD. Regarding emotional instability, female HC displayed higher instability than HC males, while no significant sex differences emerged in SSD.
Conclusion: This study shows significant sex differences in emotional experiences among SSD and HC, with different sex patterns in SSD. Targeted, sex-specific interventions are crucial for improving emotional regulation and treatment outcomes in SSD.Trial registration: ISRCTN.org identifier: ISRCTN21141466.
{"title":"Emotional experiences in male and female participants with schizophrenia spectrum disorders and healthy controls: an experience sampling method study.","authors":"Elisa Caselani, Alessandra Martinelli, Chiara Grigis, Manuel Zamparini, Elena Toffol, Philip D Harvey, Matteo C Malvezzi, Giovanni de Girolamo","doi":"10.1080/13546805.2025.2482539","DOIUrl":"10.1080/13546805.2025.2482539","url":null,"abstract":"<p><strong>Aim: </strong>Schizophrenia spectrum disorders (SSD) are associated with disturbances in emotional experience, but sex differences and comparisons to healthy controls (HC) remain poorly explored. This exploratory study used Experience Sampling Method (ESM) to examine emotional variability, instability and daily/hourly patterns of positive and negative emotions across sexes in SSD and HC.</p><p><strong>Methods: </strong>A total of 103 SSD participants (47.9%) were compared to 112 HC (52.1%), matched for sex and age. Data on sociodemographics, clinical status, functioning and quality of life were collected. ESM assessed emotional experiences over one week.</p><p><strong>Results: </strong>For positive emotions, HC males reported higher levels on weekdays and morning-to-midday hours, whereas no sex differences emerged in SSD. Males with SSD showed greater weekly variability in positive emotions than HC males, while no significant differences were found among females. For negative emotions, females with SSD exhibited greater daily variability than female HC, with no significant sex differences within HC or SSD. Regarding emotional instability, female HC displayed higher instability than HC males, while no significant sex differences emerged in SSD.</p><p><strong>Conclusion: </strong>This study shows significant sex differences in emotional experiences among SSD and HC, with different sex patterns in SSD. Targeted, sex-specific interventions are crucial for improving emotional regulation and treatment outcomes in SSD.<b>Trial registration:</b> ISRCTN.org identifier: ISRCTN21141466.</p>","PeriodicalId":51277,"journal":{"name":"Cognitive Neuropsychiatry","volume":" ","pages":"43-62"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143765763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-02-19DOI: 10.1080/13546805.2025.2467974
Molly A Erickson, Charlotte Li, Sonia Bansal, James Waltz, Philip Corlett, James Gold
Among people with schizophrenia (PSZ), positive symptoms such as hallucinations and delusions are often conceptualised as resulting from abnormal top-down modulation of sensory information. PSZ often exhibit reduced susceptibility to visual illusions compared to healthy control subjects (HCS), suggesting that top-down impairments yield enhanced perception of stimuli that would otherwise be distorted by contextualising visual elements. However, it remains unknown whether resistance to illusions is uniquely associated with positive symptoms, or if it is associated with some other aspect of serious mental illness. To examine this question, 77 PSZ, 50 HCS, and 40 individuals who hear voices and hold unusual beliefs but do not have a psychiatric illness (nonclinical voice hearers; NCVH) completed a hollow mask illusion task. HCS reported experiencing the illusion significantly more often than PSZ and more often than NCVH at the trend level, whereas the latter two groups did not differ from one another. Additionally, there was no consistent association between illusion perception and symptom severity for either PSZ or NCVH. We interpret these results to indicate that resistance to visual illusions may mark a vulnerability for experiencing voices and holding unusual beliefs; however, it may not be associated with the severity of these symptoms.
{"title":"Depth inversion illusion and its relationship to positive symptoms in clinical and non-clinical voice hearers.","authors":"Molly A Erickson, Charlotte Li, Sonia Bansal, James Waltz, Philip Corlett, James Gold","doi":"10.1080/13546805.2025.2467974","DOIUrl":"10.1080/13546805.2025.2467974","url":null,"abstract":"<p><p>Among people with schizophrenia (PSZ), positive symptoms such as hallucinations and delusions are often conceptualised as resulting from abnormal top-down modulation of sensory information. PSZ often exhibit reduced susceptibility to visual illusions compared to healthy control subjects (HCS), suggesting that top-down impairments yield enhanced perception of stimuli that would otherwise be distorted by contextualising visual elements. However, it remains unknown whether resistance to illusions is uniquely associated with positive symptoms, or if it is associated with some other aspect of serious mental illness. To examine this question, 77 PSZ, 50 HCS, and 40 individuals who hear voices and hold unusual beliefs but do not have a psychiatric illness (nonclinical voice hearers; NCVH) completed a hollow mask illusion task. HCS reported experiencing the illusion significantly more often than PSZ and more often than NCVH at the trend level, whereas the latter two groups did not differ from one another. Additionally, there was no consistent association between illusion perception and symptom severity for either PSZ or NCVH. We interpret these results to indicate that resistance to visual illusions may mark a vulnerability for experiencing voices and holding unusual beliefs; however, it may not be associated with the severity of these symptoms.</p>","PeriodicalId":51277,"journal":{"name":"Cognitive Neuropsychiatry","volume":" ","pages":"31-42"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12033074/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143460522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}